Literature DB >> 1703735

Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters.

B A Bray1, P M Sampson, M Osman, A Giandomenico, G M Turino.   

Abstract

Intratracheal instillation of bleomycin in hamsters initiates a series of events that mimic human interstitial pulmonary fibrosis. Because glycosaminoglycans and particularly hyaluronan (hyaluronic acid, HA), may play an important role in the extracellular matrix response to early injury and subsequent fibrosis, this study was undertaken to define the early time course of changes in HA and hyaluronidase. Hamsters were given either 1 unit bleomycin sulfate in 0.2 ml saline or 0.2 ml saline (control), and randomly selected animals from both groups were killed at Days 3, 5, 6, 7, 9, and 17. Glycosaminoglycan fractions prepared from lung tissue of individual animals were analyzed for HA. The maximal HA content was reached 6 days after instillation of bleomycin and was 14.6-fold the normal value. The weight of injured lungs was 2.3-fold the control value. Thus, the increase in HA content was 30-fold. By Day 7 the HA content had dropped sharply. It then declined gradually to approximately double control values at Day 17. The specific activity of lysosomal hyaluronidase was the same in bleomycin-treated lungs and control lungs. Total units of the enzyme were increased in injured lungs, even at the time of maximal HA content, indicating active turnover of HA. The maximal HA content occurs prior to the rise in collagen and elastin biosynthesis. This observation in addition to the magnitude of the increase and its abrupt decline suggest that HA may be an important initiating factor for pathologic changes in lung extracellular matrix components.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703735     DOI: 10.1164/ajrccm/143.2.284

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM.

Authors:  R C Savani; C Wang; B Yang; S Zhang; M G Kinsella; T N Wight; R Stern; D M Nance; E A Turley
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

2.  Expression of CD44 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs.

Authors:  M Kasper; A Bierhaus; A Whyte; R M Binns; D Schuh; M Müller
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

3.  Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44.

Authors:  K Svee; J White; P Vaillant; J Jessurun; U Roongta; M Krumwiede; D Johnson; C Henke
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 4.  Modulators of inflammation in Bronchopulmonary Dysplasia.

Authors:  Rashmin C Savani
Journal:  Semin Perinatol       Date:  2018-10-02       Impact factor: 3.300

Review 5.  Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

6.  Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.

Authors:  Laura M Chang; Prateesh Maheshwari; Sheila Werth; Lana Schaffer; Steven R Head; Carrie Kovarik; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

7.  Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep.

Authors:  A M Cantin; P Larivée; M Martel; R Bégin
Journal:  Lung       Date:  1992       Impact factor: 2.584

Review 8.  Hyaluronan and cell locomotion.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

9.  Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase.

Authors:  P M Sampson; C L Rochester; B Freundlich; J A Elias
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 10.  Potential therapeutic applications of hyaluronan in the lung.

Authors:  Jerome O Cantor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.